{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:47:53Z","timestamp":1792453673897,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002636","name":"Inje University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ijrobp.2020.12.031","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T21:08:34Z","timestamp":1609189714000},"page":"510-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1"],"prefix":"10.1016","volume":"110","author":[{"given":"Jin Hee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kyeong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Seon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SaeGwang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2020.12.031_bib1","doi-asserted-by":"crossref","first-page":"59820","DOI":"10.18632\/oncotarget.10930","article-title":"Improved survival of patients with hepatocellular carcinoma and disparities by age, race, and socioeconomic status by decade, 1983-2012","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4304817","article-title":"The combination of stereotactic body radiation therapy and immunotherapy in primary liver tumors","volume":"2019","author":"Kreidieh","year":"2019","journal-title":"J Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib5","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.3748\/wjg.v22.i30.6851","article-title":"Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"Yu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.critrevonc.2017.01.017","article-title":"The synergistic effect of radiotherapy and immunotherapy: a promising but not simple partnership","volume":"111","author":"Chajon","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrc.2018.6","article-title":"Using immunotherapy to boost the abscopal effect","volume":"18","author":"Ngwa","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1593\/tlo.12280","article-title":"A systemic complete response of metastatic melanoma to local radiation and immunotherapy","volume":"5","author":"Hiniker","year":"2012","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJMoa1112824","article-title":"Immunologic correlates of the abscopal effect in a patient with melanoma","volume":"366","author":"Postow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib10","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28518","article-title":"Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death","volume":"3","author":"Golden","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12609-017-0234-y","article-title":"The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer?","volume":"9","author":"Hu","year":"2017","journal-title":"Curr Breast Cancer Rep"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.it.2018.06.001","article-title":"Immunological mechanisms responsible for radiation-induced abscopal effect","volume":"39","author":"Rodriguez-Ruiz","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.currproblcancer.2015.10.001","article-title":"Systematic review of case reports on the abscopal effect","volume":"40","author":"Abuodeh","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171559","article-title":"A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?","volume":"12","author":"Marconi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fonc.2014.00325","article-title":"Combinations of immunotherapy and radiation in cancer therapy","volume":"4","author":"Vatner","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib18","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib19","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib21","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI127726","article-title":"The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy","volume":"129","author":"Wei","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000438631","article-title":"Hepatocellular carcinoma cells induce regulatory T cells and lead to poor prognosis via production of transforming growth factor-beta1","volume":"38","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ijo.2012.1497","article-title":"The role of hepatic stellate cells in the regulation of T-cell function and the promotion of hepatocellular carcinoma","volume":"41","author":"Zhao","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib24","article-title":"A protocol for the comprehensive flow cytometric analysis of immune cells in normal and inflamed murine non-lymphoid tissues","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4939-7568-6_23","article-title":"Isolation and characterization of mouse intrahepatic lymphocytes by flow cytometry","volume":"1725","author":"Wiede","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib26","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib28","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-14-1258","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume":"74","author":"Dovedi","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1084\/jem.20160801","article-title":"PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity","volume":"214","author":"Juneja","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1259\/0007-1285-26-305-234","article-title":"Whole body irradiation; radiobiology or medicine?","volume":"26","author":"Mole","year":"1953","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib31","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMc1203984","article-title":"Abscopal effect in a patient with melanoma","volume":"366","author":"Hiniker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib32","doi-asserted-by":"crossref","DOI":"10.4161\/onci.28780","article-title":"Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy","volume":"3","author":"Grimaldi","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40425-016-0156-7","article-title":"Current clinical trials testing the combination of immunotherapy with radiotherapy","volume":"4","author":"Kang","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/1078-0432.CCR-08-1277","article-title":"Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade","volume":"15","author":"Pilones","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib36","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1158\/1078-0432.CCR-09-0265","article-title":"Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody","volume":"15","author":"Dewan","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1158\/2326-6066.CIR-14-0138","article-title":"PD-1 restrains radiotherapy-induced abscopal effect","volume":"3","author":"Park","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib39","first-page":"3445","article-title":"Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment","volume":"26","author":"Shi","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib40","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3748\/wjg.v25.i20.2416","article-title":"Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma","volume":"25","author":"Choi","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 prevents cell-intrinsic initiation of autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-16-0037","article-title":"Toward precision radiotherapy for use with immune checkpoint blockers","volume":"24","author":"Vanpouille-Box","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib43","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1158\/0008-5472.CAN-09-2982","article-title":"Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy","volume":"70","author":"Takeshima","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrc2256","article-title":"Models, mechanisms and clinical evidence for cancer dormancy","volume":"7","author":"Aguirre-Ghiso","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib45","doi-asserted-by":"crossref","first-page":"41242","DOI":"10.18632\/oncotarget.17168","article-title":"Radiation improves antitumor effect of immune checkpoint inhibitor in murine hepatocellular carcinoma model","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/hepr.12789","article-title":"Programmed cell death-1 blockade enhances response to stereotactic radiation in an orthotopic murine model of hepatocellular carcinoma","volume":"47","author":"Friedman","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2020.12.031_bib47","first-page":"929","article-title":"Clinical applications of PD-1-based therapy: a focus on pembrolizumab (MK-3475) in the management of melanoma and other tumor types","volume":"8","author":"Gangadhar","year":"2015","journal-title":"Onco Targets Ther"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620347246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301620347246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:51:07Z","timestamp":1759744267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301620347246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0360301620347246"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.031","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}